Fresh stories
Investors who purchased Replimune Group, Inc. securities between October 20, 2025, and April 10, 2026, are being urged to contact Robbins LLP regarding a pending class action lawsuit. The litigation centers on allegations that the biotechnology firm misled shareholders about the efficacy and regulatory viability of its lead cancer treatment, RP1.
After four years of operating as a hybrid startup lab, Vantora has secured $100 million from Silversmith Capital Partners to redefine its business model. The firm is shifting away from building ventures for the open market, focusing instead on creating exclusive, sovereign physical AI solutions for corporate partners.
Investors who purchased Capricor Therapeutics securities between December 17, 2025, and July 26, 2026, face a September 28, 2026, deadline to seek appointment as lead plaintiff. A class action lawsuit alleges the company misled shareholders regarding the regulatory path for its Duchenne muscular dystrophy therapy, Deramiocel.
Four nominations for the upcoming Josie Music Awards underscore a pivotal season for independent duo The Swansons. As the husband-and-wife team prepares to take the stage at Nashville’s Grand Ole Opry on September 20, they are simultaneously debuting their latest single, "Hey God, It's Me Again."
Investors who purchased Taboola.com Ltd. securities between May 6 and August 4, 2026, have until October 20 to file for lead plaintiff status. The Rosen Law Firm is spearheading the class action, alleging that the company misled shareholders regarding the quality of its publisher network and its subsequent impact on earnings.
A securities class action lawsuit filed in San Diego alleges that Bloom Energy Corporation misled shareholders by obscuring its heavy reliance on Chinese scandium. Investors who acquired company stock between February 27, 2025, and July 8, 2026, now face a September 28, 2026, deadline to seek appointment as lead plaintiff.